Malawi vs Zambia: HIV/AIDS deaths averted by antiretroviral therapy
Malawi
53,389 deaths
in 2024
Zambia
76,693 deaths
in 2024
Malawi rank
9th
Zambia rank
7th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Malawi
- Zambia
How they compare
Zambia currently reports 76,693 deaths against 53,389 deaths in Malawi, a difference of 23,304 deaths.
That makes Zambia's figure about 1.4 times Malawi's.
Across all 35 years both countries report, Zambia has been ahead every year.
Malawi ranks 9th and Zambia ranks 7th of 157 countries.
Zambia has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Malawi | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 9,707 deaths | 13,774 deaths | 4,068 deaths | Zambia |
| 2010s | 46,122 deaths | 53,855 deaths | 7,733 deaths | Zambia |
| 2020s | 53,202 deaths | 72,723 deaths | 19,521 deaths | Zambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Malawi or Zambia?
- Zambia, at 76,693 deaths against 53,389 deaths in Malawi as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Malawi and Zambia?
- 23,304 deaths, with Zambia ahead.
- How many years of comparable data are there for Malawi and Zambia?
- 35 years are reported by both, from 1990 to 2024.
- How do Malawi and Zambia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Malawi ranks 9th and Zambia ranks 7th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.